Steven L. Krill, EVP & Chief Scientific Officer at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 5,987 shares at $80.00 ($479K) on 2016-11-23, disclosed to the SEC on 2016-12-02.
Open-market sale of $479k EGRX by EVP & Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.00 | 200 | $16K | 3.3% |
| 2 | $80.00 | 1,307 | $105K | 21.8% |
| 3 | $80.00 | 1,950 | $156K | 32.6% |
| 4 | $80.00 | 2,530 | $202K | 42.3% |
| Total | $80.00 avg | 5,987 | $479K | 100% |
| Filing → |
| EGRX | SELL | 2016-12-15 | $736K | — | Filing → |
| EGRX | SELL | 2015-06-18 | $814K | — | Filing → |